In 2020 and in the years beyond, this shift to sustainable supply chain business will take shape in all levels of the supply chain. Read the full article…
CUSTOMIZED SUPPLY CHAIN SOLUTIONS
In 2020 and in the years beyond, this shift to sustainable supply chain business will take shape in all levels of the supply chain. Read the full article…
Consumer expectations for quick and accurate deliveries are expanding to all types of products. Retail supply chains must adjust to meet these expectations. Read the full article…
Experts say retailers need to implement supply chain cybersecurity strategies like training employees across departments and vetting third-party partners. Read the full article…
Twenty-nineteen has been another year of growth for global third-party logistics provider, MD Logistics. Read the full article…
As the logsitics industry continues to evolve, there are a myria of changes that I think we will be witnessing over the course of the next decade. Here’s how we are responding to those changes, now. Read the full article…
MD Logistics has been awarded the distinction of being named a Top 100 3PL by Inbound Logistics Magazine for the 8th year in a row. Read the full article…
Perhaps the most common misconception associated with automation in the supply chain is that it is replacing jobs. While this may hold some truth with regards to entry level jobs, companies who implement automation are, in fact, adding numerous new positions throughout the technology, manufacturing and logistics sectors. Read the full article…
In the rapid digital advancement of the global economy, a time for change has finally come for the operating models of shipping and logistics providers. Read the full article…
The economy is humming all cylinders, employers say they can’t find employees with the right skills, yet graduate students report a tough job market. Are advanced degrees taking students backwards in employment? Read the full article…
Public criticism and scrutiny from lawmakers will likely remain, keeping biotech and pharma under pressure. At the same time, a cooperative FDA and scientific advances in oncology, cell and gene therapy should continue to serve as a tailwind, generating new approvals and investor optimism. Digital opportunities, including in artificial intelligence, have also proved attractive to drugmakers, spurring changes among executive teams. Here are seven trends to watch as 2019 unfolds… Read the full article…